P9.01 CINACALCET MAY REDUCE ARTERIAL STIFFNESS IN PATIENTS WITH CHRONIC RENAL DISEASE AND SECONDARY HYPERPARATHYROIDISM – RESULTS OF A SMALL-SCALE, PROSPECTIVE, OBSERVATIONAL STUDY

P9.01 CINACALCET MAY REDUCE ARTERIAL STIFFNESS IN PATIENTS WITH CHRONIC RENAL DISEASE AND SECONDARY HYPERPARATHYROIDISM – RESULTS OF A SMALL-SCALE, PROSPECTIVE, OBSERVATIONAL STUDY

Bibliographic Details
Main Authors:	J. Bonet, B. Bayes, P. Fernandez-Crespo, M. Casals, J. Lopez-Ayerbe, R. Romero
Format:	Article
Language:	English
Published:	Atlantis Press 2011-11-01
Series:	Artery Research
Online Access:	https://www.atlantis-press.com/article/125928042/view

Similar Items

Cinacalcet in treatment of the secondary hyperparathyroidism relapse in patients on dialysis
by: Olga Vetchinnikova, et al.
Published: (2012-06-01)

THE CARDIOVASCULAR EFFECTS OF CINACALCET IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM
by: Sungjin Chung, et al.
Published: (2012-06-01)

Pharmacogenetic analysis of cinacalcet response in secondary hyperparathyroidism patients
by: Jeong S, et al.
Published: (2016-07-01)

Cinacalcet effect on severe hyperparathyroidism
by: Al Saran Khalid, et al.
Published: (2010-01-01)

Cinacalcet Treatment of Primary Hyperparathyroidism
by: H. M. Rothe, et al.
Published: (2011-01-01)

Cinacalcet versus Parathyroidectomy in the Treatment of Secondary Hyperparathyroidism Post Renal Transplantation
by: Soliman Amin R., et al.
Published: (2016-09-01)

PHARMACOECONOMIC EVALUATION OF TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS ON DIALYSIS WITH CINACALCET
by: R. I. Yagudina, et al.
Published: (2015-03-01)

Role of cinacalcet in the treatment of secondary hyperparathyroidism in chronic kidney disease
by: H.K. Aggarwal, et al.
Published: (2013-09-01)

CINACALCET IN TREATMENT OF HYPERPARATHYROIDISM IN RECIPIENTS OF RENAL GRAFT
by: O. N. Vetchinnikova, et al.
Published: (2014-05-01)

Clinical Use of Cinacalcet in MEN1 Hyperparathyroidism
by: V. J. Moyes, et al.
Published: (2010-01-01)

P9.01 DETERMINANTS OF ARTERIAL STIFFNESS: A 16-YEAR FOLLOW-UP FROM THE WHITEHALL II STUDY
by: N.B. Johansen, et al.
Published: (2010-12-01)

The impact of cinacalcet in the mineral metabolism markers of patients on dialysis with severe secondary hyperparathyroidism
by: Sérgio Gardano Elias Bucharles, et al.

Effectiveness of Cinacalcet in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism Not Receiving Dialysis.
by: Ariadna Pérez-Ricart, et al.
Published: (2016-01-01)

Use of cinacalcet for the management of hyperparathyroidism in patients with different degrees of renal failure
by: José M. Orellana, et al.
Published: (2016-03-01)

Long-term effect of cinacalcet hydrochloride on abdominal aortic calcification in patients on hemodialysis with secondary hyperparathyroidism
by: Nakayama K, et al.
Published: (2013-12-01)

Cinacalcet and primary hyperparathyroidism: systematic review and meta regression
by: Cheng Han Ng, et al.
Published: (2020-08-01)

Parathyroid Apoplexy Following Cinacalcet Treatment in Primary Hyperparathyroidism
by: Giulia Di Dalmazi, et al.
Published: (2018-12-01)

A Case of Hyperparathyroidism Treated With Cinacalcet During Pregnancy
by: Mohammed Bashir, MD, et al.
Published: (2019-01-01)

Cinacalcet adherence in dialysis patients with secondary hyperparathyroidism in Lombardy Region: clinical implications and costs
by: Alessandro Roggeri, et al.
Published: (2020-03-01)

Gallstones were associated with the gastrointestinal adverse events of cinacalcet in hemodialysis patients with secondary hyperparathyroidism
by: Keiichi Otsuka, et al.
Published: (2018-10-01)

Effectiveness of cinacalcet treatment for secondary hyperparathyroidism on hospitalization: Results from the MBD-5D study.
by: Shinji Asada, et al.
Published: (2019-01-01)

Effect of switching from cinacalcet to etelcalcetide on secondary hyperparathyroidism in patients undergoing hemodialysis: an ESCORT trial
by: Yuka Kurokawa, et al.
Published: (2020-12-01)

Long-term effectiveness of cinacalcet in non-dialysis patients with chronic kidney disease and secondary hyperparathyroidism
by: Ariadna Pérez-Ricart, et al.
Published: (2019-06-01)

Longitudinal changes in bone and mineral metabolism after cessation of cinacalcet in dialysis patients with secondary hyperparathyroidism
by: Irene Ruderman, et al.
Published: (2018-05-01)

Partial response to cinacalcet treatment in a patient with secondary hyperparathyroidism undergoing hemodialysis: a case report
by: Conzo Giovanni, et al.
Published: (2012-12-01)

The impact of CASR A990G polymorphism in response to cinacalcet treatment in hemodialysis patients with secondary hyperparathyroidism
by: Jaruwan Ngamkam, et al.
Published: (2021-09-01)

The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism
by: Paweena Susantitaphong, et al.
Published: (2019-01-01)

Primary Hyperparathyroidism-A Review of this Disorder and an Interesting Case Treated with Cinacalcet
by: Abdul Rafi Mohammed, et al.
Published: (2009-06-01)

Experience with cinacalcet in primary hyperparathyroidism: results after 1 year of treatment
by: Inés Luque-Fernández, et al.
Published: (2013-06-01)

Cinacalcet versus parathyroidectomy for primary hyperparathyroidism: a single centre experienc
by: Salvatore Giovinazzo, et al.
Published: (2019-11-01)

Retrospective Study Looking at Cinacalcet in the Management of Hyperparathyroidism after Kidney Transplantation
by: Habib Mawad, et al.
Published: (2017-01-01)

Failed Switching off in the MIBI-Parathyroid Scintigraphy in a Dialyzed Patient with Secondary Hyperparathyroidism Responsive to Cinacalcet Therapy
by: Piergiorgio Bolasco, et al.
Published: (2010-01-01)

Cinacalcet-Associated Resolution of Primary Hyperparathyroidism in a Patient With Normal Kidney Function
by: Son Nguyen DO, PharmD, et al.
Published: (2020-06-01)

A novel dose regimen of cinacalcet in the treatment of severe hyperparathyroidism in hemodialysis patients
by: Nabieh Al-Hilali, et al.
Published: (2011-01-01)

Paricalcitol versus Calcitriol + Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease in China: A Cost-Effectiveness Analysis
by: Zhuolin Zhang, et al.
Published: (2021-07-01)

Changes of Serum Total and Free Testosterone Concentrations in Male Chronic Hemodialysis Patients with Secondary Hyperparathyroidism in Response to Cinacalcet Treatment
by: Piotr Kuczera, et al.
Published: (2016-01-01)

Diameter of Parathyroid Glands Measured by Computed Tomography as a Predictive Indicator for Response to Cinacalcet in Dialysis Patients with Secondary Hyperparathyroidism
by: Yu Ah Hong, et al.
Published: (2015-05-01)

Clinical Benefits of an Adherence Monitoring Program in the Management of Secondary Hyperparathyroidism with Cinacalcet: Results of a Prospective Randomized Controlled Study
by: Valentina Forni Ogna, et al.
Published: (2013-01-01)

Efficacy of low-dose cinacalcet on alternate days for the treatment of secondary hyperparathyroidism in hemodialysis patients: a single-center study
by: Gojaseni P, et al.
Published: (2017-02-01)

Tolerance and efficacy of a low dose of the calcimimetic agent cinacalcet in controlling moderate to severe secondary hyperparathyroidism in hemodialysis patients
by: Salah O Bashir, et al.
Published: (2015-01-01)